These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16086767)

  • 1. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
    Tobin AM; Kirby B
    Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
    [No Abstract]   [Full Text] [Related]  

  • 2. Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
    Khosravi-Hafshejani T; Zhou Y; Dutz JP
    J Rheumatol; 2019 Apr; 46(4):437-438. PubMed ID: 30936225
    [No Abstract]   [Full Text] [Related]  

  • 3. Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
    Lutz V; Lipsker D
    Arch Dermatol; 2012 Mar; 148(3):297-9. PubMed ID: 22431771
    [No Abstract]   [Full Text] [Related]  

  • 4. Acrodermatitis Continua of Hallopeau with Granuloma-like Vegetation, Osteolysis and IL36RN Mutation.
    Qi Y; Qiu L; Zheng S; Li S; Xiao T
    Acta Derm Venereol; 2017 Jan; 97(1):122-123. PubMed ID: 27231138
    [No Abstract]   [Full Text] [Related]  

  • 5. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
    Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
    Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
    Silpa-archa N; Wongpraparut C
    J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
    Lu R; George SJ; Hsu S
    Dermatol Online J; 2006 May; 12(4):18. PubMed ID: 17083873
    [No Abstract]   [Full Text] [Related]  

  • 11. Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau.
    Rubio C; Martin MA; Arranz Sánchez DM; Vidaurrazaga C; Casado M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):707-8. PubMed ID: 18785890
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin.
    Chastagner M; Hoelt P; Kanitakis J; Jullien D; Villani AP
    Eur J Dermatol; 2019 Apr; 29(2):218-220. PubMed ID: 30827945
    [No Abstract]   [Full Text] [Related]  

  • 13. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.
    López-Ferrer A; Dalmau J; Fernández-Figueras MT; Puig L
    Cutis; 2014 Mar; 93(3):E6-7. PubMed ID: 24738108
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin.
    Gallo E; Llamas-Velasco M; Daudén E; García-Diez A
    Int J Dermatol; 2013 Dec; 52(12):1610-1. PubMed ID: 22834488
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.
    Dini V; Barbanera S; Romanelli M
    Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925
    [No Abstract]   [Full Text] [Related]  

  • 17. Unusual association between acrokeratosis verruciformis of Hopf and multiple keratoacanthomas. Successful therapy with acitretin.
    Farro P; Zalaudek I; Ferrara G; Fulgione E; Cicale L; Petrillo G; Zanchini R; Ruocco E; Argenziano G
    J Dtsch Dermatol Ges; 2004 Jun; 2(6):440-2. PubMed ID: 16281601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
    Weisshaar E; Diepgen TL
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome.
    van der Kerkhof PC; Steijlen PM; Raymakers RA
    Br J Dermatol; 1996 Apr; 134(4):754-7. PubMed ID: 8733386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrodermatitis continua of Hallopeau: response to combined treatment with acitretin and calcipotriol ointment.
    Kuijpers AL; van Dooren-Greebe RJ; van de Kerkhof PC
    Dermatology; 1996; 192(4):357-9. PubMed ID: 8864375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.